Alliancebernstein L.P. Atri Cure, Inc. Transaction History
Alliancebernstein L.P.
- $261 Billion
- Q1 2025
A detailed history of Alliancebernstein L.P. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 3,676,849 shares of ATRC stock, worth $128 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,676,849
Previous 3,835,449
4.14%
Holding current value
$128 Million
Previous $117 Million
1.2%
% of portfolio
0.05%
Previous 0.04%
Shares
25 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$161 Million0.0% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$105 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$85 Million0.1% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.2MShares$76.6 Million0.02% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.62B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...